{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:36:25Z","timestamp":1793885785417,"version":"4.8.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA241603"],"award-info":[{"award-number":["R37CA241603"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA300057"],"award-info":[{"award-number":["R01CA300057"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-23-1152630"],"award-info":[{"award-number":["RSG-23-1152630"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Leukaemic stem cells (LSCs) reside in protective bone marrow (BM) niches that promote therapeutic resistance and relapse. Here we characterized longitudinal BM niches supporting LSC survival, distinguishing the metaphysis from the central marrow. Quiescent LSCs preferentially localized to the metaphysis and exhibited reduced stemness and aggressiveness upon mobilization to the central marrow. Targeting DPP4 in acute myeloid leukaemia (AML) cells altered CXCL12 gradients at three spatial scales. Systemically, reversal of the BM\u2013peripheral blood CXCL12 gradient confined AML cells within the BM. At the BM level, disruption of the metaphysis\u2013central marrow gradient displaced LSCs from their protective niche. At the microscale, loss of the CXCL12 gradient between N-cadherin\n                    <jats:sup>+<\/jats:sup>\n                    stromal cells and the surrounding matrix impaired LSC recruitment. These effects arise from the CXCL12\u2013DPP4\u2013GPC3 axis, in which DPP4 truncates and inactivates CXCL12, whereas stromal GPC3 restrains DPP4 activity. Modulating this axis disrupts niche protection and enhances therapeutic vulnerability in AML.\n                  <\/jats:p>","DOI":"10.1038\/s41556-026-01939-3","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T09:02:14Z","timestamp":1777021334000},"page":"890-902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal localization of leukaemic stem cells between the metaphysis and central marrow governs their behaviour"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7307-9256","authenticated-orcid":false,"given":"Chen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7381-9776","authenticated-orcid":false,"given":"Yi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruochen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaduo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Nistala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7173-9414","authenticated-orcid":false,"given":"Richard D.","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9963-430X","authenticated-orcid":false,"given":"Linheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1853-1881","authenticated-orcid":false,"given":"XunLei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"1939_CR1","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.cell.2019.04.040","volume":"177","author":"N Baryawno","year":"2019","unstructured":"Baryawno, N. et al. A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia. Cell 177, 1915\u20131932 (2019).","journal-title":"Cell"},{"key":"1939_CR2","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.stem.2019.02.018","volume":"24","author":"P Agarwal","year":"2019","unstructured":"Agarwal, P. et al. Mesenchymal niche-specific expression of Cxcl12 controls quiescence of treatment-resistant leukemia stem cells. Cell Stem Cell 24, 769\u2013784 (2019).","journal-title":"Cell Stem Cell"},{"key":"1939_CR3","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/s43018-023-00607-x","volume":"4","author":"E Grockowiak","year":"2023","unstructured":"Grockowiak, E. et al. Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasms. Nat. Cancer 4, 1193\u20131209 (2023).","journal-title":"Nat. Cancer"},{"key":"1939_CR4","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2014.02.014","volume":"14","author":"H Medyouf","year":"2014","unstructured":"Medyouf, H. et al. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell 14, 824\u2013837 (2014).","journal-title":"Cell Stem Cell"},{"key":"1939_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","volume":"13","author":"K Schepers","year":"2013","unstructured":"Schepers, K. et al. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13, 285\u2013299 (2013).","journal-title":"Cell Stem Cell"},{"key":"1939_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.stem.2017.11.006","volume":"22","author":"D Duarte","year":"2018","unstructured":"Duarte, D. et al. Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML. Cell Stem Cell 22, 64\u201377 (2018).","journal-title":"Cell Stem Cell"},{"key":"1939_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","volume":"20","author":"S Mendez-Ferrer","year":"2020","unstructured":"Mendez-Ferrer, S. et al. Bone marrow niches in haematological malignancies. Nat. Rev. Cancer 20, 285\u2013298 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1939_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12984","volume":"505","author":"SJ Morrison","year":"2014","unstructured":"Morrison, S. J. & Scadden, D. T. The bone marrow niche for haematopoietic stem cells. Nature 505, 327\u2013334 (2014).","journal-title":"Nature"},{"key":"1939_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1084\/jem.185.1.111","volume":"185","author":"A Aiuti","year":"1997","unstructured":"Aiuti, A., Webb, I. J., Bleul, C., Springer, T. & Gutierrez-Ramos, J. C. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 185, 111\u2013120 (1997).","journal-title":"J. Exp. Med."},{"key":"1939_CR10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1084\/jem.20011284","volume":"195","author":"DE Wright","year":"2002","unstructured":"Wright, D. E., Bowman, E. P., Wagers, A. J., Butcher, E. C. & Weissman, I. L. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J. Exp. Med. 195, 1145\u20131154 (2002).","journal-title":"J. Exp. Med."},{"key":"1939_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0014-5793(93)81609-4","volume":"336","author":"T Hoffmann","year":"1993","unstructured":"Hoffmann, T., Faust, J., Neubert, K. & Ansorge, S. Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences. FEBS Lett. 336, 61\u201364 (1993).","journal-title":"FEBS Lett."},{"key":"1939_CR12","doi-asserted-by":"crossref","unstructured":"Christopherson, K. W. 2nd, Hangoc, G., Mantel, C. R. & Broxmeyer, H. E. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305, 1000\u20131003 (2004).","DOI":"10.1126\/science.1097071"},{"key":"1939_CR13","doi-asserted-by":"publisher","first-page":"112105","DOI":"10.1016\/j.celrep.2023.112105","volume":"42","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. Dipeptidylpeptidase 4 promotes survival and stemness of acute myeloid leukemia stem cells. Cell Rep. 42, 112105 (2023).","journal-title":"Cell Rep."},{"key":"1939_CR14","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/pmic.200600654","volume":"7","author":"J Davoodi","year":"2007","unstructured":"Davoodi, J., Kelly, J., Gendron, N. H. & MacKenzie, A. E. The Simpson\u2013Golabi\u2013Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26. Proteomics 7, 2300\u20132310 (2007).","journal-title":"Proteomics"},{"key":"1939_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1083\/jcb.200302152","volume":"163","author":"B De Cat","year":"2003","unstructured":"De Cat, B. et al. Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements. J. Cell Biol. 163, 625\u2013635 (2003).","journal-title":"J. Cell Biol."},{"key":"1939_CR16","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nature02041","volume":"425","author":"J Zhang","year":"2003","unstructured":"Zhang, J. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836\u2013841 (2003).","journal-title":"Nature"},{"key":"1939_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature07639","volume":"457","author":"Y Xie","year":"2009","unstructured":"Xie, Y. et al. Detection of functional haematopoietic stem cell niche using real-time imaging. Nature 457, 97\u2013101 (2009).","journal-title":"Nature"},{"key":"1939_CR18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.celrep.2018.12.093","volume":"26","author":"M Zhao","year":"2019","unstructured":"Zhao, M. et al. N-cadherin-expressing bone and marrow stromal progenitor cells maintain reserve hematopoietic stem cells. Cell Rep. 26, 652\u2013669 (2019).","journal-title":"Cell Rep."},{"key":"1939_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2027372","volume":"384","author":"SS Farag","year":"2021","unstructured":"Farag, S. S. et al. Dipeptidyl peptidase 4 inhibition for prophylaxis of acute graft-versus-host disease. N. Engl. J. Med. 384, 11\u201319 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1939_CR20","doi-asserted-by":"publisher","unstructured":"Namburi, S., Broxmeyer, H. E., Hong, C. S., Whiteside, T. L. & Boyiadzis, M. DPP4(+) exosomes in AML patients\u2019 plasma suppress proliferation of hematopoietic progenitor cells. Leukemia https:\/\/doi.org\/10.1038\/s41375-020-01047-7 (2020).","DOI":"10.1038\/s41375-020-01047-7"},{"key":"1939_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s13402-011-0017-9","volume":"34","author":"AC Weidenaar","year":"2011","unstructured":"Weidenaar, A. C. et al. High acute myeloid leukemia derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow. Cell. Oncol. 34, 289\u2013296 (2011).","journal-title":"Cell. Oncol."},{"key":"1939_CR22","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1182\/blood.V95.8.2637","volume":"95","author":"T Padr\u00f3","year":"2000","unstructured":"Padr\u00f3, T. et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 95, 2637\u20132644 (2000).","journal-title":"Blood"},{"key":"1939_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5507\/bp.2016.054","volume":"161","author":"T Kupsa","year":"2017","unstructured":"Kupsa, T., Vanek, J., Pavel, Z., Jebavy, L. & Horacek, J. M. Serum levels of soluble adhesion molecules in newly diagnosed acute myeloid leukemia and in complete remission suggest endothelial cell activation by myeloblasts. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 161, 92\u201399 (2017).","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub."},{"key":"1939_CR24","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1021\/ja909524e","volume":"132","author":"AD Tinoco","year":"2010","unstructured":"Tinoco, A. D., Tagore, D. M. & Saghatelian, A. Expanding the dipeptidyl peptidase 4-regulated peptidome via an optimized peptidomics platform. J. Am. Chem. Soc. 132, 3819\u20133830 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"1939_CR25","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.2741\/2800","volume":"13","author":"TB Campbell","year":"2008","unstructured":"Campbell, T. B. & Broxmeyer, H. E. CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation. Front. Biosci. 13, 1795\u20131805 (2008).","journal-title":"Front. Biosci."},{"key":"1939_CR26","doi-asserted-by":"crossref","unstructured":"Ohnuma, K. & Marimoto, C. DPP4 (dipeptidyl-peptidase 4). In Atlas of Genetics and Cytogenetics in Oncology and Haematology (2012); http:\/\/atlasgeneticsoncology.org\/Genes\/DPP4ID40360ch2q24.html","DOI":"10.4267\/2042\/49697"},{"key":"1939_CR27","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/nm.2991","volume":"18","author":"HE Broxmeyer","year":"2012","unstructured":"Broxmeyer, H. E. et al. Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis. Nat. Med. 18, 1786\u20131796 (2012).","journal-title":"Nat. Med."},{"key":"1939_CR28","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1126\/science.283.5403.845","volume":"283","author":"A Peled","year":"1999","unstructured":"Peled, A. et al. Dependence of human stem cell engraftment and repopulation of NOD\/SCID mice on CXCR4. Science 283, 845\u2013848 (1999).","journal-title":"Science"},{"key":"1939_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/ni813","volume":"3","author":"I Petit","year":"2002","unstructured":"Petit, I. et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3, 687\u2013694 (2002).","journal-title":"Nat. Immunol."},{"key":"1939_CR30","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1172\/JCI94687","volume":"127","author":"P Singh","year":"2017","unstructured":"Singh, P. et al. Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells. J. Clin. Invest. 127, 4527\u20134540 (2017).","journal-title":"J. Clin. Invest."},{"key":"1939_CR31","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41586-021-03298-5","volume":"591","author":"B Shen","year":"2021","unstructured":"Shen, B. et al. A mechanosensitive peri-arteriolar niche for osteogenesis and lymphopoiesis. Nature 591, 438\u2013444 (2021).","journal-title":"Nature"},{"key":"1939_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.stem.2014.06.008","volume":"15","author":"BO Zhou","year":"2014","unstructured":"Zhou, B. O., Yue, R., Murphy, M. M., Peyer, J. G. & Morrison, S. J. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 15, 154\u2013168 (2014).","journal-title":"Cell Stem Cell"},{"key":"1939_CR33","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.immuni.2018.03.024","volume":"48","author":"Q Wei","year":"2018","unstructured":"Wei, Q. & Frenette, P. S. Niches for hematopoietic stem cells and their progeny. Immunity 48, 632\u2013648 (2018).","journal-title":"Immunity"},{"key":"1939_CR34","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nature02040","volume":"425","author":"LM Calvi","year":"2003","unstructured":"Calvi, L. M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841\u2013846 (2003).","journal-title":"Nature"},{"key":"1939_CR35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature11885","volume":"495","author":"L Ding","year":"2013","unstructured":"Ding, L. & Morrison, S. J. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 495, 231\u2013235 (2013).","journal-title":"Nature"},{"key":"1939_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature11926","volume":"495","author":"A Greenbaum","year":"2013","unstructured":"Greenbaum, A. et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 495, 227\u2013230 (2013).","journal-title":"Nature"},{"key":"1939_CR37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S Mendez-Ferrer","year":"2010","unstructured":"Mendez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829\u2013834 (2010).","journal-title":"Nature"},{"key":"1939_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/jbmr.203","volume":"26","author":"X Lu","year":"2011","unstructured":"Lu, X. et al. Identification of the homeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterix expression and mediator of tumor necrosis factor alpha action in osteoblast differentiation. J. Bone Miner. Res. 26, 209\u2013219 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"1939_CR39","doi-asserted-by":"publisher","first-page":"115521","DOI":"10.1016\/j.bone.2020.115521","volume":"139","author":"A Esposito","year":"2020","unstructured":"Esposito, A., Wang, L., Li, T., Miranda, M. & Spagnoli, A. Role of Prx1-expressing skeletal cells and Prx1-expression in fracture repair. Bone 139, 115521 (2020).","journal-title":"Bone"},{"key":"1939_CR40","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.devcel.2014.03.013","volume":"29","author":"T Mizoguchi","year":"2014","unstructured":"Mizoguchi, T. et al. Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development. Dev. Cell 29, 340\u2013349 (2014).","journal-title":"Dev. Cell"},{"key":"1939_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","volume":"32","author":"D Forte","year":"2020","unstructured":"Forte, D. et al. Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy. Cell Metab. 32, 829\u2013843 (2020).","journal-title":"Cell Metab."},{"key":"1939_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41556-022-00849-4","volume":"24","author":"S Pinho","year":"2022","unstructured":"Pinho, S. et al. VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells. Nat. Cell Biol. 24, 290\u2013298 (2022).","journal-title":"Nat. Cell Biol."},{"key":"1939_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41388-022-02536-y","volume":"42","author":"D Ma","year":"2023","unstructured":"Ma, D. et al. Intracellular angiopoietin-1 promotes TKI-resistance via activation of JAK\/STAT5 pathway in chronic myeloid leukemia. Oncogene 42, 124\u2013137 (2023).","journal-title":"Oncogene"},{"key":"1939_CR44","first-page":"642","volume":"6","author":"N Carlesso","year":"1992","unstructured":"Carlesso, N. et al. Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool. Leukemia 6, 642\u2013648 (1992).","journal-title":"Leukemia"},{"key":"1939_CR45","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/sj.leu.2401136","volume":"12","author":"LJ Bendall","year":"1998","unstructured":"Bendall, L. J. et al. Stem cell factor enhances the adhesion of AML cells to fibronectin and augments fibronectin-mediated anti-apoptotic and proliferative signals. Leukemia 12, 1375\u20131382 (1998).","journal-title":"Leukemia"},{"key":"1939_CR46","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.stem.2019.10.003","volume":"25","author":"L Kunz","year":"2019","unstructured":"Kunz, L. & Schroeder, T. A 3D tissue-wide digital imaging pipeline for quantitation of secreted molecules shows absence of CXCL12 gradients in bone marrow. Cell Stem Cell 25, 846\u2013854 (2019).","journal-title":"Cell Stem Cell"},{"key":"1939_CR47","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/cmi.2017.107","volume":"15","author":"R Janssens","year":"2018","unstructured":"Janssens, R., Struyf, S. & Proost, P. The unique structural and functional features of CXCL12. Cell. Mol. Immunol. 15, 299\u2013311 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"1939_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84695-8","volume":"11","author":"XY Cui","year":"2021","unstructured":"Cui, X. Y. et al. Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia. Sci. Rep. 11, 5127 (2021).","journal-title":"Sci. Rep."},{"key":"1939_CR49","doi-asserted-by":"publisher","first-page":"107684","DOI":"10.1016\/j.celrep.2020.107684","volume":"31","author":"R Ramakrishnan","year":"2020","unstructured":"Ramakrishnan, R. et al. CXCR4 signaling has a CXCL12-independent essential role in murine MLL-AF9-driven acute myeloid leukemia. Cell Rep. 31, 107684 (2020).","journal-title":"Cell Rep."},{"key":"1939_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2020-142579","volume":"136","author":"NR Anderson","year":"2020","unstructured":"Anderson, N. R. et al. CXCL12 knock-out enhances leukemia stem cell response to combination chemotherapy plus tyrosine kinase inhibition in Flt3-ITD acute myeloid leukemia. Blood 136, 7\u20138 (2020).","journal-title":"Blood"},{"key":"1939_CR51","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1182\/blood-2008-05-158311","volume":"113","author":"Z Zeng","year":"2009","unstructured":"Zeng, Z. et al. Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood 113, 6215\u20136224 (2009).","journal-title":"Blood"},{"key":"1939_CR52","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature19801","volume":"538","author":"ED Hawkins","year":"2016","unstructured":"Hawkins, E. D. et al. T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments. Nature 538, 518\u2013522 (2016).","journal-title":"Nature"},{"key":"1939_CR53","doi-asserted-by":"publisher","first-page":"634044","DOI":"10.3389\/fcell.2021.634044","volume":"9","author":"FM Roversi","year":"2021","unstructured":"Roversi, F. M., Bueno, M. L. P., Pericole, F. V. & Saad, S. T. O. Hematopoietic cell kinase (HCK) is a player of the crosstalk between hematopoietic cells and bone marrow niche through CXCL12\/CXCR4 axis. Front. Cell Dev. Biol. 9, 634044 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1939_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17594-7","volume":"11","author":"MLR Haltalli","year":"2020","unstructured":"Haltalli, M. L. R. & Lo Celso, C. Targeting adhesion to the vascular niche to improve therapy for acute myeloid leukemia. Nat. Commun. 11, 3691 (2020).","journal-title":"Nat. Commun."},{"key":"1939_CR55","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1182\/blood-2017-12-784132","volume":"131","author":"D Duarte","year":"2018","unstructured":"Duarte, D., Hawkins, E. D. & Lo Celso, C. The interplay of leukemia cells and the bone marrow microenvironment. Blood 131, 1507\u20131511 (2018).","journal-title":"Blood"},{"key":"1939_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02376-5","volume":"9","author":"O Akinduro","year":"2018","unstructured":"Akinduro, O. et al. Proliferation dynamics of acute myeloid leukaemia and haematopoietic progenitors competing for bone marrow space. Nat. Commun. 9, 519 (2018).","journal-title":"Nat. Commun."},{"key":"1939_CR57","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1182\/blood.2021010721","volume":"139","author":"DJ DeAngelo","year":"2022","unstructured":"DeAngelo, D. J. et al. Phase 1\/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia. Blood 139, 1135\u20131146 (2022).","journal-title":"Blood"},{"key":"1939_CR58","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1182\/bloodadvances.2021006166","volume":"6","author":"J Versluis","year":"2022","unstructured":"Versluis, J. et al. Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy. Blood Adv. 6, 2835\u20132846 (2022).","journal-title":"Blood Adv."},{"key":"1939_CR59","doi-asserted-by":"publisher","first-page":"5423694","DOI":"10.1155\/2022\/5423694","volume":"2022","author":"T Chen","year":"2022","unstructured":"Chen, T., Zhang, J., Wang, Y. & Zhou, H. Identification of survival-related genes in acute myeloid leukemia (AML) based on cytogenetically normal AML samples using weighted gene coexpression network analysis. Dis. Markers 2022, 5423694 (2022).","journal-title":"Dis. Markers"},{"key":"1939_CR60","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.bmc.2009.01.061","volume":"17","author":"SH Havale","year":"2009","unstructured":"Havale, S. H. & Pal, M. Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes. Bioorg. Med. Chem. 17, 1783\u20131802 (2009).","journal-title":"Bioorg. Med. Chem."},{"key":"1939_CR61","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/jca.21588","volume":"33","author":"A Cline","year":"2018","unstructured":"Cline, A., Jajosky, R., Shikle, J. & Bollag, R. Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis. J. Clin. Apher. 33, 396\u2013400 (2018).","journal-title":"J. Clin. Apher."},{"key":"1939_CR62","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clml.2017.09.008","volume":"18","author":"C Del Prete","year":"2018","unstructured":"Del Prete, C., Kim, T., Lansigan, F., Shatzel, J. & Friedman, H. The epidemiology and clinical associations of stroke in patients with acute myeloid leukemia: a review of 10,972 admissions from the 2012 national inpatient sample. Clin. Lymphoma Myeloma Leuk. 18, 74\u201377 (2018).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"1939_CR63","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.1182\/blood-2008-06-162123","volume":"113","author":"B Nervi","year":"2009","unstructured":"Nervi, B. et al. Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood 113, 6206\u20136214 (2009).","journal-title":"Blood"},{"key":"1939_CR64","doi-asserted-by":"crossref","unstructured":"Marciano, R. et al. High-throughput screening identified compounds sensitizing tumor cells to glucose starvation in culture and VEGF inhibitors in vivo. Cancers https:\/\/doi.org\/10.3390\/cancers11020156 (2019).","DOI":"10.3390\/cancers11020156"},{"key":"1939_CR65","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1111\/jcmm.17259","volume":"26","author":"M Khorsand","year":"2022","unstructured":"Khorsand, M. et al. Telmisartan anti-cancer activities mechanism through targeting N-cadherin by mimicking ADH-1 function. J. Cell. Mol. Med. 26, 2392\u20132403 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"1939_CR66","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41556-020-00601-w","volume":"22","author":"MLR Haltalli","year":"2020","unstructured":"Haltalli, M. L. R. et al. Manipulating niche composition limits damage to haematopoietic stem cells during Plasmodium infection. Nat. Cell Biol. 22, 1399\u20131410 (2020).","journal-title":"Nat. Cell Biol."},{"key":"1939_CR67","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1182\/blood-2009-02-206565","volume":"115","author":"DC Taussig","year":"2010","unstructured":"Taussig, D. C. et al. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(\u2212) fraction. Blood 115, 1976\u20131984 (2010).","journal-title":"Blood"},{"key":"1939_CR68","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ccr.2011.06.029","volume":"20","author":"Y Kikushige","year":"2011","unstructured":"Kikushige, Y. et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell 20, 246\u2013259 (2011).","journal-title":"Cancer Cell"},{"key":"1939_CR69","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen, P. et al. Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell 176, 1265\u20131281 (2019).","journal-title":"Cell"},{"key":"1939_CR70","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/immu.200310005","volume":"33","author":"J De Boer","year":"2003","unstructured":"De Boer, J. et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33, 314\u2013325 (2003).","journal-title":"Eur. J. Immunol."},{"key":"1939_CR71","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1182\/blood-2004-08-3037","volume":"105","author":"JR Gothert","year":"2005","unstructured":"Gothert, J. R. et al. In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis. Blood 105, 2724\u20132732 (2005).","journal-title":"Blood"},{"key":"1939_CR72","first-page":"30","volume":"11","author":"X Kang","year":"2018","unstructured":"Kang, X. & Wang, C. CAMKs support development of acute myeloid leukemia. J. Exp. Med. 11, 30 (2018).","journal-title":"J. Exp. Med."},{"key":"1939_CR73","doi-asserted-by":"crossref","unstructured":"Zheng, J. et al. Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature 488, 656\u2013660 (2012).","DOI":"10.1038\/nature11095"},{"key":"1939_CR74","doi-asserted-by":"publisher","first-page":"eadl5931","DOI":"10.1126\/scitranslmed.adl5931","volume":"16","author":"Y Pan","year":"2024","unstructured":"Pan, Y. et al. Inhibiting AGTR1 reduces AML burden and protects the heart from cardiotoxicity in mouse models. Sci. Transl. Med. 16, eadl5931 (2024).","journal-title":"Sci. Transl. Med."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01939-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01939-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01939-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:02:36Z","timestamp":1778857356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01939-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1939"],"URL":"https:\/\/doi.org\/10.1038\/s41556-026-01939-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6515437\/v1","asserted-by":"object"}]},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}